Ackman endorses HHH thesis as he aims to build compounding machine
- Bill Ackman endorsed a report highlighting the valuation disconnect in Howard Hughes Holdings (HHH) shares.
- Pershing Square holds a 46.9% stake after investing $900 million at $100 per share in May 2025.
- HHH completed the $2.1 billion acquisition of Vantage Group Holdings to serve as its insurance engine.
- The stock trades at a trailing P/E of 11.901, significantly below the industry average of 32.850.
- Ackman aims to transform HHH into a compounding machine resembling Berkshire Hathaway over 50 years.

*this image is generated using AI for illustrative purposes only.
Pershing Square CEO Bill Ackman endorsed an analysis of the pricing discount in Howard Hughes Holdings Inc. (NYSE: HHH) shares, reinforcing his strategy to transition the firm into a capital holding company. Ackman stated that the market is missing this shift because "no one is paying attention" to the business.
Valuation Disconnect and Ownership
On Sept. 21, Ackman shared an analysis by Scott Felsenthal on social media platform X, describing it as "an excellent and insightful report on $HHH." The report highlights a disconnect between HHH's current market price of roughly $62 per share and its underlying asset values.
Fifteen months earlier, in May 2025, Pershing Square invested $900 million to purchase 9 million newly issued HHH shares at $100 per share. It holds a 46.9% beneficial ownership stake in HHH.
According to the company's own valuation framework, the real estate assets alone are estimated at $82 per share. Ackman recently stated that the liquidation value of these real estate assets is "north of $100" per share.
Despite these metrics, the market continues to price HHH as a traditional real estate developer. Ackman addressed this in a Sept. 8 podcast, stating, "We literally, yesterday, made a big announcement which I am sure you missed because no one is paying attention to this company."
The 'Compounding Machine' Strategy
Pershing Square intends to transform HHH into an entity resembling Berkshire Hathaway Inc.'s economic architecture. The strategy relies on utilizing excess cash generated from HHH's real estate to fund specialty insurance and public equity investing.
In June, HHH completed the $2.1 billion acquisition of Vantage Group Holdings to serve as the primary insurance engine. To support this transition, HHH appointed former Arch Capital CEO Marc Grandisson as Executive Chair of Vantage, who personally invested $10 million to purchase warrants with a $100 exercise price.
Ackman has outlined an ambition for permanent ownership. He described the long-term vision on a recent podcast as creating a "compounding machine over the next 50 years" with the ultimate goal of building a trillion-dollar enterprise over time.
Stock Performance and Metrics
With a market cap of $3.591 billion, HHH stock was trading 1.15% higher in Monday's premarket. It was down 28.03% over the last year, 24.51% year-to-date, and 8.42% over the last month.
The stock closed 2.14% lower at $60.22 on Friday. According to Benzinga Pro, HHH's trailing price-to-earnings ratio is 11.901, as compared to the industry average of 32.850.
Benzinga's Edge Stock Rankings indicate that OPTH maintains a weak price trend in the short, medium and long terms, with a good value score.
What the Numbers Show
The data reveals a significant divergence between investor entry costs and current market pricing. Pershing Square acquired its stake at $100 per share, while the stock recently traded around $62 per share. This implies a substantial unrealized loss on the initial investment relative to the current market price, despite Ackman's assertion that the underlying asset value exceeds $82 per share based on the company's framework.
How might the integration of Vantage Group Holdings impact HHH's cash flow stability and ability to fund future equity investments in the short term?
What specific catalysts or milestones are required for the market to re-rate HHH from a traditional developer to a 'Berkshire-style' holding company?
Could Pershing Square's significant unrealized loss on its $100 entry price create pressure to exit the position if the stock does not recover toward intrinsic value?


























